In yesterday's thread on "Jevtana and Prednisone", no mention was made of the potential effect of prednisone on the cancer. In fact, Eric wrote that: "prednisone in itself does nothing to stop or slow the cancer".
In fact, there may be add-on value in the combined treatments where prednisone is included for other reasons.
From the bad old days:
1] 1998 - Effect of predisone on PSA in CRPC. "10 mg of prednisone orally two times a day."
"The mean and median PSA decline after initiating prednisone was 33%"
"Ten patients (34%) had a PSA decline of more than 50% and 4 patients (14%) had PSA declines of more than 75%."
2] 2001 - Flutamide versus prednisone in CRPC.
"In symptomatic HRPC, treatment with prednisone or flutamide leads to similar rates of {time to progression} and overall survival and no difference in subjective or biochemical response. The QL results favor the use of low-cost prednisone in patients with HRPC."
-Patrick